Ontology highlight
ABSTRACT: Introduction
There have been few studies investigating acute kidney injury (AKI) in patients with yellow fever (YF). The objective of this study was to identify the risk factors for AKI and death in such patients.Methods
We evaluated 95 consecutive critically ill adult patients with the sylvatic form of YF, as confirmed by reverse-transcriptase polymerase chain reaction, in Brazil. The outcome measures were AKI (as defined by Kidney Disease: Improving Global Outcomes [KDIGO] criteria) and in-hospital death.Results
Of the 95 patients, 73 (76.8%) had AKI and 59 (62.1%) died from it. A total of 70 patients (73.7%) required dialysis because of AKI. After adjusting for age, sex, and the Simplified Acute Physiology Score 3 (SAPS 3), we found that elevated fractional excretion of sodium and requiring dialysis were independent risk factors for in-hospital mortality and that proteinuria correlated with AKI-associated mortality.Conclusion
Our findings indicate that, in patients with sylvatic YF, AKI is common and is associated with significant mortality. The data presented here could prove useful for improving understanding of the pathogenesis of AKI in YF and informing decisions regarding the care of the affected patients.
SUBMITTER: Arantes MF
PROVIDER: S-EPMC8897308 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
Arantes Márcia Fernanda MF Seabra Victor Faria VF Lins Paulo Ricardo Gessolo PRG Rodrigues Camila Eleuterio CE Reichert Bernardo Vergara BV Silveira Marcelo Augusto Duarte MAD Li Ho Yeh HY Malbouisson Luiz Marcelo LM Andrade Lúcia L
Kidney international reports 20211222 3
<h4>Introduction</h4>There have been few studies investigating acute kidney injury (AKI) in patients with yellow fever (YF). The objective of this study was to identify the risk factors for AKI and death in such patients.<h4>Methods</h4>We evaluated 95 consecutive critically ill adult patients with the sylvatic form of YF, as confirmed by reverse-transcriptase polymerase chain reaction, in Brazil. The outcome measures were AKI (as defined by Kidney Disease: Improving Global Outcomes [KDIGO] crit ...[more]